ask="N/A"
ask_size="N/A"
average_daily_volume="379425"
bid="1.00"
bid_size="100"
book_value="14.23"
change="-0.59"
change_from_200_day_moving_average="-9.52"
change_from_50_day_moving_average="-4.69"
change_from_52_week_high="-21.02"
change_From_52_week_low="7.05"
change_in_percent="-1.45%"
close="39.96"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.44"
ebitda="-97.47M"
eps_estimate_current_year="-4.38"
eps_estimate_next_quarter="-1.15"
eps_estimate_next_year="-3.84"
ex_dividend_date="N/A"
float_shares="24661000"
high="40.58"
high_52_weeks="60.98"
last_trade_date="3/16/2017"
last_trade_price="39.96"
last_trade_size="23176"
last_trade_time="4:00pm"
low="39.39"
low_52_weeks="32.91"
market_capitalization="1.10B"
moving_average_200_day="49.48"
moving_average_50_day="44.65"
name="Five Prime Therapeutics
Inc."
notes="N/A"
one_year_target_price="65.29"
open="40.56"
pe_ratio="N/A"
peg_ratio="0.16"
percent_change_from_200_day_moving_average="-19.24%"
percent_change_from_50_day_moving_average="-10.51%"
percent_change_from_52_week_high="-34.47%"
percent_change_from_52_week_low="+21.42%"
previous_close="40.55"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.85"
price_per_sales="36.35"
revenue="30.69M"
shares_outstanding="27509000"
short_ratio="9.22"
stock_exchange="NMS"
symbol="FPRX"
volume="415961"
weeks_range_52="32.91 - 60.98"
